Skip to main content

Letybo Side Effects

Generic name: letibotulinumtoxinA

Note: This document provides detailed information about Letybo.

Applies to letibotulinumtoxinA: intramuscular powder for injection Side Effects associated with letibotulinumtoxinA. Some dosage forms listed on this page may not apply specifically to the brand name Letybo.

Applies to letibotulinumtoxinA: intramuscular powder for injection.

General

The most common adverse reaction occurring in more than 2% of patients was headache. Adverse reactions may occur within the first few days following injection and may have a transient duration of up to several months or longer.[Ref]

Dermatologic

Gastrointestinal

Immunologic

Local

Metabolic

Musculoskeletal

Ocular

Respiratory

Nervous system

References

1. (2023) "Product Information. Letybo (letibotulinumtoxinA)." Croma Aesthetics Canada, Ltd

2. (2022) "Product Information. Letybo (letibotulinumtoxinA)." CROMA Australia Pty Ltd, 1

3. (2024) "Product Information. Letybo (letibotulinumtoxinA)." Hugel Aesthetics

Frequently asked questions

Further information

Letybo side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.